Literature DB >> 10958382

Human eosinophil-airway smooth muscle cell interactions.

J M Hughes1, C A Arthur, S Baracho, S M Carlin, K M Hawker, P R Johnson, C L Armour.   

Abstract

Eosinophils are present throughout the airway wall of asthmatics. The nature of the interaction between human airway smooth muscle cells (ASMC) and eosinophils was investigated in this study. We demonstrated, using light microscopy, that freshly isolated eosinophils from healthy donors rapidly attach to ASMC in vitro. Numbers of attached eosinophils were highest at 2 h, falling to 50% of maximum by 20 h. Eosinophil attachment at 2 h was reduced to 72% of control by anti-VCAM-1, and to 74% at 20 h by anti-ICAM-1. Pre-treatment of ASMC for 24h with TNF-alpha, 10 nM, significantly increased eosinophil adhesion to 149 and 157% of control after 2 and 20 h. These results provide evidence that eosinophil interactions with ASMC involve VCAM-1 and ICAM-1 and are modulated by TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10958382      PMCID: PMC1781747          DOI: 10.1080/096293500411550

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  34 in total

1.  Effect of fibronectin on the production of leukotriene C4 by eosinophils.

Authors:  K Yoshida; M Suko; G Matsuzaki; H Sugiyama; H Okudaira; K Ito
Journal:  Int Arch Allergy Immunol       Date:  1995       Impact factor: 2.749

Review 2.  Biology of interleukin-5 and its relevance to allergic disease.

Authors:  R W Egan; S P Umland; F M Cuss; R W Chapman
Journal:  Allergy       Date:  1996-02       Impact factor: 13.146

3.  Extracellular matrix proteins attenuate activation and degranulation of stimulated eosinophils.

Authors:  H Kita; S Horie; G J Gleich
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

Review 4.  Tumour necrosis factor alpha: a potential mediator of asthma.

Authors:  A Shah; M K Church; S T Holgate
Journal:  Clin Exp Allergy       Date:  1995-11       Impact factor: 5.018

5.  Cytokines directly induce degranulation and superoxide production from human eosinophils.

Authors:  S Horie; G J Gleich; H Kita
Journal:  J Allergy Clin Immunol       Date:  1996-08       Impact factor: 10.793

6.  Adhesion to fibronectin augments eosinophil radical oxygen products.

Authors:  I Higashimoto; J Chihara; T Kakazu; T Yamamoto; D Kurachi; S Nakajima
Journal:  Int Arch Allergy Immunol       Date:  1995       Impact factor: 2.749

7.  IL-1 beta and IL-6 induce hyperplasia and hypertrophy of cultured guinea pig airway smooth muscle cells.

Authors:  S De; E T Zelazny; J F Souhrada; M Souhrada
Journal:  J Appl Physiol (1985)       Date:  1995-04

Review 8.  The role of eosinophils in the pathogenesis of asthma.

Authors:  M C Seminario; G J Gleich
Journal:  Curr Opin Immunol       Date:  1994-12       Impact factor: 7.486

9.  Adhesion of activated eosinophils to respiratory epithelial cells is enhanced by tumor necrosis factor-alpha and interleukin-1 beta.

Authors:  V Godding; J M Stark; J B Sedgwick; W W Busse
Journal:  Am J Respir Cell Mol Biol       Date:  1995-11       Impact factor: 6.914

10.  Heparin and PGE2 inhibit DNA synthesis in human airway smooth muscle cells in culture.

Authors:  P R Johnson; C L Armour; D Carey; J L Black
Journal:  Am J Physiol       Date:  1995-10
View more
  16 in total

Review 1.  Does airway smooth muscle express an inflammatory phenotype in asthma?

Authors:  Gautam Damera; Reynold A Panettieri
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

2.  Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction.

Authors:  Mourad Zerfaoui; Yasuhiro Suzuki; Amarjit S Naura; Chetan P Hans; Charles Nichols; A Hamid Boulares
Journal:  Cell Signal       Date:  2007-10-12       Impact factor: 4.315

3.  IL-6 trans-signaling increases expression of airways disease genes in airway smooth muscle.

Authors:  Mac B Robinson; Deepak A Deshpande; Jeffery Chou; Wei Cui; Shelly Smith; Carl Langefeld; Annette T Hastie; Eugene R Bleecker; Gregory A Hawkins
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-05-22       Impact factor: 5.464

4.  Eosinophils induce airway smooth muscle cell proliferation.

Authors:  Rabih Halwani; Alejandro Vazquez-Tello; Yuki Sumi; Mary Angeline Pureza; Ahmed Bahammam; Hamdan Al-Jahdali; Abdelillah Soussi-Gounni; Bassam Mahboub; Saleh Al-Muhsen; Qutayba Hamid
Journal:  J Clin Immunol       Date:  2012-11-23       Impact factor: 8.317

Review 5.  Airway smooth muscle in the pathophysiology and treatment of asthma.

Authors:  Diana C Doeing; Julian Solway
Journal:  J Appl Physiol (1985)       Date:  2013-01-10

Review 6.  Targeting airway smooth muscle in airways diseases: an old concept with new twists.

Authors:  Cynthia J Koziol-White; Gautam Damera; Reynold A Panettieri
Journal:  Expert Rev Respir Med       Date:  2011-12       Impact factor: 3.772

7.  Phosphorylation of p50 NF-kappaB at a single serine residue by DNA-dependent protein kinase is critical for VCAM-1 expression upon TNF treatment.

Authors:  Jihang Ju; Amarjit S Naura; Youssef Errami; Mourad Zerfaoui; Hogyoung Kim; Jong G Kim; Zakaria Y Abd Elmageed; Asim B Abdel-Mageed; Charles Giardina; Amer A Beg; Mark E Smulson; A Hamid Boulares
Journal:  J Biol Chem       Date:  2010-10-21       Impact factor: 5.157

8.  Distribution of major basic protein on human airway following in vitro eosinophil incubation.

Authors:  Ailing Xue; John Wang; Gary C Sieck; Mark E Wylam
Journal:  Mediators Inflamm       Date:  2010-03-22       Impact factor: 4.711

Review 9.  Airway smooth muscle as an immunomodulatory cell.

Authors:  Gautam Damera; Omar Tliba; Reynold A Panettieri
Journal:  Pulm Pharmacol Ther       Date:  2008-12-24       Impact factor: 3.410

Review 10.  Factors controlling transduction signaling and proliferation of airway smooth muscle.

Authors:  J L Black; P R Johnson; C L Armour
Journal:  Curr Allergy Asthma Rep       Date:  2001-03       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.